Viewing Compound With Activities

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Gene Compound Experiment Study Pathway Assay Report Bug Request Feature

Compound Report Overview

Compound Name: VATALANIB

Compound Identifier: 704211

Mol Structure 2D: 704211

Molecular Weight: 347

Formula: C20 H15 Cl N4

Development Status: Clinical, Phase II/III

SMILES: Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1

Activities CAS Curations Identifiers Literature Properties Similarities SMILES Structures Synonyms Targets

Compound Literature

Compound	Gene Type	Activity	Description	View

VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.077	inhibits, kinase activity, recombinant purifed VEGF receptor Flk1	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View
VATALANIB	IC50	.037	inhibits, kinase activity, recombinant purified VEGF receptor/KDR	View